Literature DB >> 20561987

MCP-induced protein 1 suppresses TNFalpha-induced VCAM-1 expression in human endothelial cells.

Yongfen Qi1, Jian Liang, Zhi-Gang She, Yan Cai, Jing Wang, Tianhua Lei, William B Stallcup, Mingui Fu.   

Abstract

Endothelial inflammation plays a critical role in the development and progression of cardiovascular disease, albeit the mechanisms need to be fully elucidated. We here report that treatment of human umbilical vein endothelial cells (HUVECs) with tumor necrosis factor (TNF) alpha substantially increased the expression of MCP-induced protein 1 (MCPIP1). Overexpression of MCPIP1 protected ECs against TNFalpha-induced endothelial activation, as characterized by the attenuation in the expression of the adhesion molecule VCAM-1 and monocyte adherence to ECs. Conversely, small interfering RNA-mediated knock down of MCPIP1 increased the expression of VCAM-1 and monocytic adherence to ECs. These studies identified MCPIP1 as a feedback control of cytokines-induced endothelial inflammation. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561987      PMCID: PMC3587133          DOI: 10.1016/j.febslet.2010.05.040

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-kappa B and GATA motifs.

Authors:  T Minami; W C Aird
Journal:  J Biol Chem       Date:  2001-10-05       Impact factor: 5.157

2.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

Authors:  L Gu; Y Okada; S K Clinton; C Gerard; G K Sukhova; P Libby; B J Rollins
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

3.  Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.

Authors:  L Boring; J Gosling; M Cleary; I F Charo
Journal:  Nature       Date:  1998-08-27       Impact factor: 49.962

Review 4.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

5.  Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1beta mRNA.

Authors:  Danuta Mizgalska; Paulina Wegrzyn; Krzysztof Murzyn; Aneta Kasza; Aleksander Koj; Jacek Jura; Barbara Jarzab; Jolanta Jura
Journal:  FEBS J       Date:  2009-12       Impact factor: 5.542

6.  Silymarin inhibits TNF-alpha-induced expression of adhesion molecules in human umbilical vein endothelial cells.

Authors:  Jong Soon Kang; Song-Kyu Park; Kyu-Hwan Yang; Hwan Mook Kim
Journal:  FEBS Lett       Date:  2003-08-28       Impact factor: 4.124

Review 7.  In vivo properties of monocyte chemoattractant protein-1.

Authors:  L Gu; B Rutledge; J Fiorillo; C Ernst; I Grewal; R Flavell; R Gladue; B Rollins
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

Review 8.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 9.  Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease.

Authors:  B J Rollins
Journal:  Mol Med Today       Date:  1996-05

10.  KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation.

Authors:  Sucharita SenBanerjee; Zhiyong Lin; G Brandon Atkins; Daniel M Greif; Ravi M Rao; Ajay Kumar; Mark W Feinberg; Zhiping Chen; Daniel I Simon; F William Luscinskas; Thomas M Michel; Michael A Gimbrone; Guillermo García-Cardeña; Mukesh K Jain
Journal:  J Exp Med       Date:  2004-05-10       Impact factor: 14.307

View more
  17 in total

1.  Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1.

Authors:  Sonam Dhamija; Reinhard Winzen; Anneke Doerrie; Gesine Behrens; Nancy Kuehne; Celina Schauerte; Elena Neumann; Oliver Dittrich-Breiholz; Michael Kracht; Helmut Holtmann
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

Review 2.  Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets.

Authors:  Richard F Keep; Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; David A Antonetti; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-08       Impact factor: 6.200

3.  Monocyte Chemotactic Protein-induced Protein 1 and 4 Form a Complex but Act Independently in Regulation of Interleukin-6 mRNA Degradation.

Authors:  Shengping Huang; Shufeng Liu; Jia J Fu; T Tony Wang; Xiaolan Yao; Anil Kumar; Gang Liu; Mingui Fu
Journal:  J Biol Chem       Date:  2015-07-01       Impact factor: 5.157

4.  Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.

Authors:  Yong Li; Shengping Huang; Xuan Huang; Xiuzhen Li; Adrian Falcon; Adele Soutar; Frederic Bornancin; Zhisheng Jiang; Hong-Bo Xin; Mingui Fu
Journal:  Cell Signal       Date:  2018-06-18       Impact factor: 4.315

5.  Monocyte chemotactic protein-induced protein 1 controls allergic airway inflammation by suppressing IL-5-producing TH2 cells through the Notch/Gata3 pathway.

Authors:  Hui Peng; Huan Ning; Qinghong Wang; Wenbao Lu; Yingzi Chang; Tony T Wang; Jinping Lai; Pappachan E Kolattukudy; Rong Hou; Daniel F Hoft; Mark S Dykewicz; Jianguo Liu
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

6.  MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells.

Authors:  Shufeng Liu; Chao Qiu; Ruidong Miao; Jianhua Zhou; Aram Lee; Baoming Liu; Sandra N Lester; Weihui Fu; Lingyan Zhu; Linxia Zhang; Jianqing Xu; Daping Fan; Kui Li; Mingui Fu; Tianyi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

7.  Zc3h12c inhibits vascular inflammation by repressing NF-κB activation and pro-inflammatory gene expression in endothelial cells.

Authors:  Ling Liu; Zhou Zhou; Shengping Huang; Yanhong Guo; Yanbo Fan; Ji Zhang; Jifeng Zhang; Mingui Fu; Y Eugene Chen
Journal:  Biochem J       Date:  2013-04-01       Impact factor: 3.857

8.  MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression.

Authors:  Wenbao Lu; Huan Ning; Ling Gu; Hui Peng; Qinghong Wang; Rong Hou; Mingui Fu; Daniel F Hoft; Jianguo Liu
Journal:  Cancer Res       Date:  2016-02-01       Impact factor: 12.701

9.  Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines.

Authors:  Jian Liang; Jing Wang; Yasser Saad; Logan Warble; Edilu Becerra; Pappachan E Kolattukudy
Journal:  J Neuroinflammation       Date:  2011-12-24       Impact factor: 8.322

10.  MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo.

Authors:  Zhuqing Jin; Jian Liang; Jing Wang; Pappachan E Kolattukudy
Journal:  J Neuroinflammation       Date:  2015-02-27       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.